Q2 Recalls Snapshot: Recall Events Rise 31% While Recalled Units Slide

Medical device recalls initiated in the second quarter of 2020 increased 31% from the previous quarter, marking the largest number of corrections and removals in a quarter in two years. Check out our Q2 recalls infographic.

Q2 Device Recalls

Medical device recalls initiated in the second quarter of 2020 mushroomed 31% from the previous quarter, marking the largest number of corrections and removals in a quarter in two years. There were 341 recalls in Q2, compared to 260 in Q1. “While the average recall size was lower than the previous quarter, this level of recall activity puts the industry on track to experience about 1,200 recalls by year end,” consulting firm Stericycle says in its most recent recalls index. “This annual activity would represent a 35% increase over last year. And it’s worth noting that this activity does not include unofficial recalls of face masks and other personal protection equipment handled at the state level.”

Meanwhile, industry recalled 29,405,138 device units in Q2, a 92% decrease from Q1, when 355.1 million units were pulled from...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Recalls

FDA Rebukes Four Companies, Including One Overseas, For Procedural Failures

 

The US FDA’s device center sent warning letters to three domestic device manufacturers and one German firm for failing to adhere to protocol on several issues.

California Medtech Firms Resolve Patent Dispute Over Delivery Catheters

 

Route 92 says it has reached a settlement with Q’Apel Medical over patent claims concerning its Tenzing delivery catheters.

Q’Apel Medical Recalls, Discontinues Stroke Therapy System After FDA Warning Letter, Class I Designation

 

Q’Apel Medical has pulled its aspiration system for stroke thrombectomy from the market after concerns raised by the US FDA in a February warning letter.

Makary Proposes Combined Adverse Event Reporting Systems In Megyn Kelly Interview

 

In discussing FDA’s adverse event monitoring, Makary also seemed to falsely imply the agency did not fully investigate the myocarditis signal with COVID-19 vaccines.

More from Policy & Regulation

Where Do Questions Surrounding The EU’s AI Act Leave The Medtech Industry?

 

The EU’s Artificial Intelligence Act, which entered into force on 1 August 2024, is already facing turbulence.

Medtech Giants Brace for Tariffs Impact: Responses Range From Financial To Philosophical

 

Manufacturing shifts, financial planning, and supply chain changes are among the adjustments that medtech leaders are making to Trump-era tariffs. Medtech Insight’s review of first-quarter earnings calls reveals how firms are navigating the impact and uncertainty of evolving trade policies.

Global Medtech Guidance Tracker: May 2025

 
• By 

Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Thirty-six documents have been posted on the tracker since its last update.